• Policy
• Phase 2 of Shinpoong's Pyramax will be conducted again
• by Lee, Hye-Kyung Jun 16, 2022 05:57am

• Company
• GC Pharma leads 300 billion flu vaccine market
• by Nho, Byung Chul Jun 15, 2022 07:48pm

• Policy
• HIRA to review metformin+SGLT2+DPP4 reimb at last
• by Lee, Tak-Sun Jun 15, 2022 05:51am

• Policy
• Policies at a standstill due to absence of MFDS minister
• by Lee, Jeong-Hwan Jun 15, 2022 05:50am

• Company
• Samsung Bioepis Announces Phase 3 Results of Soliris Similar
• by Kim, Jin-Gu Jun 15, 2022 05:50am

• Policy
• Lorviqua is about to be reimbursed
• by Lee, Tak-Sun Jun 15, 2022 05:50am

• Company
• Sales of topical minoxidil rise with interest in hair loss
• by Jun 14, 2022 06:04am

• Company
• Lilly Korea has entered into negotiations on Emgality
• by Eo, Yun-Ho Jun 14, 2022 06:04am

• Policy
• MFDS reviews EUA of COVID-19 prevention drug Evusheld
• by Lee, Hye-Kyung Jun 14, 2022 06:04am

• Company
• Whether Gardasil 9's supply price increase is reasonable
• by Jun 14, 2022 06:04am